The University of Liverpool has partnered with Boston-based BPGbio, Inc. to use artificial intelligence to accelerate the discovery of new medicines through its Civic HealthTech Innovation Zone, ...

CBSE Class 12 Biology last 10 days study plan for board exam 2026 with detailed day-wise revision strategy, daily timetable, high-weightage chapters, and exam-focused tips.

BILL , the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, today announced financial results for the second fiscal quarter ended December 31 ...

Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

BBSRC and Defra have launched a £3 million Diet and Health Collaborative Research and Development programme to drive food innovation and improve health outcomes in the UK. The jointly funded ...

At 31 October 2025, net liabilities of the Group amounted to £8.4 million (30 April 2025: £3.8 million) and it held cash of £8.6 million (30 April 2025: £16.9 million). R&D tax credits of £3.0 million ...

Diagram-based learning helps students understand complex Biology concepts, improve recall, and perform better in board exams. By combining visual memory with active learning, diagrams simplify ...

Virtus Westchester Event-Driven Fund returned 1.04% in the fourth quarter, bringing year‑to‑date performance to 7.89%.

Researchers in Class of 1942 Professor of Chemistry Matthew D. Shoulders' lab have uncovered a sinister hidden mechanism that ...

In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease ...